FIRST REQUEST FOR EOI FOR WHO EVALUATION OF MOLECULAR ASSAYS FOR DETECTION OF YELLOW FEVER VIRUS

The Expanded Programme on Immunization (“EPI”) of the World Health Organization (“WHO”) invites manufacturers of monoplex or multiplex molecular assays that detect nucleic acid specific to Yellow Fever virus (hereinafter “NATs”) to submit an expression of interest for product evaluation in accordance with this Invitation (“Invitation”). Manufacturers of NATs meeting the minimum requirements set forth in this Invitation are invited to respond in the form required by WHO and to submit their products, as and when directed by WHO, for evaluation and testing under the WHO Evaluation Programme of Molecular Assays for Yellow Fever virus (“Evaluation Programme”).
For consideration under the Evaluation Programme, manufacturers must complete, in its entirety, the form in Annex 1 and must return the completed and signed form together with the required documentation to WHO by the deadline stated on the first page of this Invitation. Any missing or unclear information, or failure to submit by the deadline, may be grounds for WHO to exclude a product for consideration for this first invitation. Such Expression of Interest will not be binding on either WHO or the manufacturer but should be received by WHO by 31/08/2020 at the latest.
Participation in the Evaluation Programme means acceptance by the applicant of the terms and conditions of this Invitation (including the annexes).

NOTE: ALL EMAIL CORRESPONDENCE MUST BEAR THE EOI REFERENCE NUMBER